Novakivskyy, V. 2017. “PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION”. Ukrainian Journal of Nephrology and Dialysis, no. 1(53) (March), 26-31. https://doi.org/10.31450/ukrjnd.1(53).2017.04.